Table 1a Patient demographics and pathological features for Ovarian cancer
Characteristics | Frequencies | Percentages (%) |
|---|---|---|
Pathology | ||
 Serous cystadenocarcinoma | 88 | 56 |
 Endometrioid | 33 | 21 |
 Clear cell carcinoma | 21 | 13 |
 Mucinous cystadenocarcinoma | 12 | 8 |
 Other | 3 | 2 |
Grade | ||
 1 | 20 | 13 |
 2 | 23 | 14 |
 3 | 114 | 73 |
Residual tumour | ||
 None | 88 | 56 |
 Present | 69 | 44 |
Stage | ||
 IC | 44 | 28 |
 II | 21 | 13 |
 III | 71 | 45 |
 IV | 21 | 14 |
Chemotherapy | ||
 Carboplatin monotherapy | 65 | 41 |
 Carboplatin combination therapy | 89 | 57 |
 No chemotherapy | 3 | 2 |
Platinum sensitivity | ||
 Sensitive | 104 | 66 |
 Resistant | 50 | 32 |
 Unknown | 3 | 2 |
Relapse status | ||
 Relapsed | 75 | 48 |
 Relapse-free | 75 | 48 |
 Unknown | 7 | 4 |
Survival status | ||
 Living | 103 | 66 |
 Dead | 54 | 34 |
